Kansas City, Mo. – September 12, 2026 -- Google DeepMind has released AlphaGenome Atlas, a one-petabyte AI resource containing molecular-effect predictions for more than 9 billion possible single-letter DNA changes across the human genome, giving researchers browser-based access to the largest catalogue of its kind without writing code.

Cambridge, Massachusetts – September 12, 2026 -- Frost & Sullivan has named ZAGENO its 2026 North America Life Sciences E-Commerce Company of the Year, citing the platform's shift from online marketplace to full procurement orchestration infrastructure for research organizations.

Carlsbad, Calif. – September 12, 2026 -- Tyra Biosciences, Inc. (Nasdaq: TYRA) will hold a virtual fireside chat and one-on-one investor meetings at the Cantor Global Healthcare Conference 2026 on Wednesday, September 9, 2026 at 1:00 PM ET.

Clinical-stage biotech to address investors from New York event

The presentation, though based in New York, NY, will be conducted virtually, with a live webcast accessible via the "For Investors" section of Tyra's website. A replay will be made available following the session.

New York – September 12, 2026 -- Rosen Law Firm has filed a securities class action against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) covering purchasers of the company's securities between December 29, 2025 and June 29, 2026.

Cleveland – September 12, 2026 -- The Austin Company and its affiliate Austin Consulting will exhibit at the 2026 ISPE Annual Meeting and Expo, running October 18-21 at the Gaylord National Resort and Convention Center in National Harbor, Maryland.

Shanghai – September 12, 2026 -- CorrectSequence Therapeutics (Correctseq) reported that its transformer Base Editor (tBE) therapy CS-101/CS-206 delivered durable clinical remission in patients with sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) across four distinct genetic backgrounds, according to a peer-reviewed study published in Cell Stem Cell on September 7, 2026.

Sugar Land, Texas – September 12, 2026 -- QuVa Pharma, Inc. has acquired a range of essential medications from Central Admixture Pharmacy Services, Inc. (CAPS) after CAPS decided to exit the 503B sterile compounding business.

Shanghai – September 11, 2026 -- Natural Field has expanded its NF TriSolve® nutraceutical solutions platform into the sleep wellness category with the launch of NF TriSolve® SleepRestore Complex, targeting a growing segment of the global nutrition market.

Salt Lake City – September 11, 2026 -- A decade-long study by ARUP Laboratories found that 50% of pregnancies with atypical prenatal cell-free DNA (cfDNA) screening results carried at least one clinically significant abnormality confirmed by follow-up testing, reshaping how providers should respond to inconclusive genetic screens.

New York – September 11, 2026 -- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) and certain of its officers, alleging violations of federal securities laws tied to the company's handling of a third-party manufacturing vendor's compliance issues.